Treatment of AIDS with Drugs Targeted to Inhibit Different Stages of the HIV Life Cycle
- 1 January 1995
- journal article
- review article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 17 (2) , 217-245
- https://doi.org/10.3109/08923979509019748
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- The Immunopathogenesis of Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1993
- HIV Inhibitors Targeted at the Reverse TranscriptaseAIDS Research and Human Retroviruses, 1992
- Use of Drugs Targeted to Inhibit Different Stages of the HIV Life Cycle in the Treatment of AIDSPublished by Springer Nature ,1992
- A Novel, Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase (Review)Published by Springer Nature ,1992
- Targeted therapy of human immunodeficiency virus‐related diseaseThe FASEB Journal, 1991
- In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-DideoxyinosineScience, 1989
- Molecular Pharmacologic Approaches to the Treatment of AidsAnnual Review of Pharmacology and Toxicology, 1988
- The AIDS VirusScientific American, 1987
- Inhibition of HTLV-III/LAV replication by foscarnetBiochemical Pharmacology, 1985
- INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III IN VITRO BY PHOSPHONOFORMATEThe Lancet, 1985